Maze Therapeutics (MAZE) Institutional Ownership $10.28 +0.11 (+1.08%) As of 05/23/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Maze Therapeutics (NASDAQ:MAZE)Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$273.87MNumber ofInstitutional Sellers(last 12 months)0 Get MAZE Insider Trade Alerts Want to know when executives and insiders are buying or selling Maze Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MAZE Institutional Buying and Selling by Quarter Maze Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Woodline Partners LP929,102$10.23M0.1%N/A2.121% 5/16/2025 Octagon Capital Advisors LP468,000$5.15M0.6%N/A1.069% 5/16/2025 Goldman Sachs Group Inc.13,129$145K0.0%N/A0.030% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,135$57K0.0%N/A0.012% 5/16/2025 ARCH Venture Management LLC4,120,053$45.36M22.0%N/A9.407% 5/16/2025 Alyeska Investment Group L.P.125,000$1.38M0.0%N/A0.285% 5/15/2025 Frazier Life Sciences Management L.P.4,129,001$45.46M2.1%N/A9.428% 5/15/2025 Hhlr Advisors LTD.457,535$5.04M0.1%N/A1.045% 5/15/2025 Ghisallo Capital Management LLC30,000$330K0.0%N/A0.068% 5/15/2025 Driehaus Capital Management LLC132,115$1.46M0.0%N/A0.302% Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2025 Affinity Asset Advisors LLC250,000$2.75M0.3%N/A0.571% 5/14/2025 Corebridge Financial Inc.4,328$48K0.0%N/A0.010% 5/14/2025 Matrix Capital Management Company LP2,486,184$27.37M7.9%N/A5.677% 5/12/2025 Nuveen LLC11,375$125K0.0%N/A0.026% 5/12/2025 Invesco Ltd.20,552$226K0.0%N/A0.047% 5/9/2025 Deutsche Bank AG8,885$98K0.0%N/A0.020% 5/9/2025 TRV GP V LLC950,800$10.47M8.4%N/A2.171% 5/9/2025 TRV GP IV LLC6,073,958$66.87M72.0%N/A13.869% 5/9/2025 Charles Schwab Investment Management Inc.72,305$796K0.0%N/A0.165% 5/9/2025 Harvard Management Co. Inc.637,528$7.02M0.6%N/A1.456% 5/2/2025 Alphabet Inc.2,412,471$26.56M1.7%N/A5.508% 5/1/2025 New York State Common Retirement Fund2,300$25K0.0%N/A0.005% 4/29/2025 Bank of New York Mellon Corp17,233$190K0.0%N/A0.039% 4/23/2025 Bessemer Group Inc.481,790$5.31M0.0%N/A1.100% 4/16/2025 General Catalyst Group Management LLC1,035,910$11.41M1.3%N/A2.365% (Data available from 1/1/2016 forward) MAZE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MAZE shares? During the previous two years, 25 institutional investors and hedge funds held shares of Maze Therapeutics. The most heavily invested institutionals were TRV GP IV LLC ($66.87M), Frazier Life Sciences Management L.P. ($45.46M), ARCH Venture Management LLC ($45.36M), Matrix Capital Management Company LP ($27.37M), Alphabet Inc. ($26.56M), General Catalyst Group Management LLC ($11.41M), and TRV GP V LLC ($10.47M).Learn more on MAZE's institutional investors. Which institutional investors have been buying Maze Therapeutics stock? Of the 25 institutional investors that purchased Maze Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TRV GP IV LLC ($6.07M), Frazier Life Sciences Management L.P. ($4.13M), ARCH Venture Management LLC ($4.12M), Matrix Capital Management Company LP ($2.49M), Alphabet Inc. ($2.41M), General Catalyst Group Management LLC ($1.04M), and TRV GP V LLC ($950.80K). How much institutional buying is happening at Maze Therapeutics? Institutional investors have bought a total of 24,874,689 shares in the last 24 months. This purchase volume represents approximately $273.87M in transactions. Related Companies Indivior Institutional Ownership IDEAYA Biosciences Institutional Ownership Edgewise Therapeutics Institutional Ownership Immunocore Institutional Ownership Mesoblast Institutional Ownership Travere Therapeutics Institutional Ownership Structure Therapeutics Institutional Ownership Evotec Institutional Ownership Janux Therapeutics Institutional Ownership Adaptive Biotechnologies Institutional Ownership This page (NASDAQ:MAZE) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAZE Stock Free MAZE Stock Alerts